Researchers conducted a seven-month study involving all patients in two ventilator-dependent wards. For three months, one ward received treated textiles, while the other did not. After one month of both wards using untreated textiles, another three-month period began in which the wards flipped — the other received untreated textiles, and vice versa.
They found using copper oxide-infused textiles was associated with a 23 percent decrease in days of antibiotic treatment and a 27.5 percent decrease in antibiotic daily dose per 1,000 hospitalization days. Also, there were fewer antibiotic treatment initiation events and fewer fever days when the copper textiles were in use.
“Using copper oxide–impregnated biocidal textiles may be an important measure aimed at reducing HAIs in long-term care medical settings,” the study concludes.
More articles on patient safety:
Maryland hospital NICU reopens 4 months after investigation into bacteria outbreak
Study: To reduce readmissions, involve caregivers in discharge planning
Can a simple congratulatory text message up hand hygiene compliance?
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
